Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease

被引:82
作者
Farfel-Becker, Tamar [1 ]
Vitner, Einat B. [1 ]
Pressey, Sarah N. R. [3 ]
Eilam, Raya [2 ]
Cooper, Jonathan D. [3 ]
Futerman, Anthony H. [1 ]
机构
[1] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel
[2] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel
[3] Kings Coll London, Pediat Storage Disorders Lab, Dept Neurosci,Ctr Neurodegenerat Res, Ctr Cellular Basis Behav,MRC,Inst Psychiat, London WC2R 2LS, England
关键词
NIGRA PARS RETICULATA; BRAIN-STEM RESPONSE; GLUCOCEREBROSIDASE MUTATIONS; CEROID-LIPOFUSCINOSIS; ABNORMALITIES; ACTIVATION; CHILDREN; MARKER;
D O I
10.1093/hmg/ddr019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gaucher disease (GD), the most common lysosomal storage disorder, is caused by a deficiency in the lysosomal enzyme glucocerebrosidase (GlcCerase), which results in intracellular accumulation of glucosylceramide (GlcCer). The rare neuronopathic forms of GD are characterized by profound neurological impairment and neuronal cell death, but little is known about the neuropathological changes that underlie these events. We now systematically examine the onset and progression of various neuropathological changes (including microglial activation, astrogliosis and neuron loss) in a mouse model of neuronopathic GD, and document the brain areas that are first affected, which may reflect vulnerability of these areas to GlcCerase deficiency. We also identify neuropathological changes in several brain areas and pathways, such as the substantia nigra reticulata, reticulotegmental nucleus of the pons, cochlear nucleus and the somatosensory system, which could be responsible for some of the neurological manifestations of the human disease. In addition, we establish that microglial activation and astrogliosis are spatially and temporally correlated with selective neuron loss.
引用
收藏
页码:1375 / 1386
页数:12
相关论文
共 36 条
  • [1] The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease
    Altarescu, G
    Hill, S
    Wiggs, E
    Jeffries, N
    Kreps, C
    Parker , CC
    Brady, RO
    Barton, NW
    Schiffmann, R
    Bannarjee, TK
    Crutchfield, K
    Frei, K
    McKee, MA
    Moore, DF
    Tournay, A
    [J]. JOURNAL OF PEDIATRICS, 2001, 138 (04) : 539 - 547
  • [2] Inflammation in neurodegenerative diseases
    Amor, Sandra
    Puentes, Fabiola
    Baker, David
    van der Valk, Paul
    [J]. IMMUNOLOGY, 2010, 129 (02) : 154 - 169
  • [3] Audiometric abnormalities in children with Gaucher disease type 3
    Bamiou, DE
    Campbell, P
    Liasis, A
    Page, J
    Sirimanna, T
    Boyd, S
    Vellodi, A
    Harris, C
    [J]. NEUROPEDIATRICS, 2001, 32 (03) : 136 - 141
  • [4] Anatomical substrates of oculomotor control
    Büttner-Ennever, JA
    Horn, AKE
    [J]. CURRENT OPINION IN NEUROBIOLOGY, 1997, 7 (06) : 872 - 879
  • [5] Deterioration of the auditory brainstem response in children with type 3 Gaucher disease
    Campbell, PE
    Harris, CM
    Vellodi, A
    [J]. NEUROLOGY, 2004, 63 (02) : 385 - 387
  • [6] A model of neuronopathic Gaucher disease
    Campbell, PE
    Harris, CM
    Sirimanna, T
    Vellodi, A
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2003, 26 (07) : 629 - 639
  • [7] Murine models of acute neuronopathic Gaucher disease
    Enquist, Ida Berglin
    Lo Bianco, Christophe
    Ooka, Andreas
    Nilsson, Eva
    Mansson, Jan-Eric
    Ehinger, Mats
    Richter, Johan
    Brady, Roscoe O.
    Kirik, Deniz
    Karlsson, Stefan
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (44) : 17483 - 17488
  • [8] No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease
    Farfel-Becker, Tamar
    Vitner, Einat
    Dekel, Hani
    Leshem, Noa
    Enquist, Ida Berglin
    Karlsson, Stefan
    Futerman, Anthony H.
    [J]. HUMAN MOLECULAR GENETICS, 2009, 18 (08) : 1482 - 1488
  • [9] Franklin BJ., 2008, The Mouse Brain in Stereotaxic Coordinates, V3rd
  • [10] Somatosensory evoked potentials as a marker of disease burden in type 3 Gaucher disease
    Garvey, MA
    Toro, C
    Goldstein, S
    Altarescu, G
    Wiggs, EA
    Hallett, M
    Schiffmann, R
    [J]. NEUROLOGY, 2001, 56 (03) : 391 - 394